What Researchers Did
Researchers surgically treated 10 patients with peripheral arterial disease and chronic lower limb ulcers by injecting autologous adipose-derived regenerative cells (ADRCs) into the ulcer edges.
What They Found
All 10 patients treated with autologous adipose-derived regenerative cells (ADRCs) showed a reduction in both the diameter and depth of their chronic lower limb ulcers. This reduction was observed during monitoring periods up to 90 days and was associated with a decrease in pain.
What This Means for Canadian Patients
This research suggests that autologous adipose-derived regenerative cells (ADRCs) could offer a promising new therapeutic option for Canadian patients suffering from chronic lower limb ulcers due to peripheral arterial disease. If proven effective in larger studies, this approach might improve wound healing and reduce pain, potentially enhancing quality of life for those with difficult-to-treat ulcers.
Canadian Relevance
This study was not conducted in Canada and has no direct Canadian connection.
Study Limitations
A significant limitation of this study is the very small sample size of only 10 treated patients, which limits the generalizability of the findings.